Idorsia Ltd: Swissmedic Approves Quviviq (Daridorexant) – A Treatment For Insomnia

Idorsia Ltd IDIA:

• SWISSMEDIC APPROVES QUVIVIQ (DARIDOREXANT) – A FIRST-IN-CLASS TREATMENT FOR CHRONIC INSOMNIA DISORDER TO IMPROVE BOTH NIGHTTIME SYMPTOMS AND DAYTIME FUNCTIONING

• AIMS TO MAKE QUVIVIQ AVAILABLE TO PATIENTS WITH CHRONIC INSOMNIA DISORDER IN SWITZERLAND AROUND MID-2023